1. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein
   Soichiro Saikawa et al, 2018, Cancer Letters CrossRef
2. Antitumor Effect of Zinc Acetate in Hepatocellular Carcinoma Cell Lines via the Induction of Apoptosis
   Rie HASHIMOTO et al, 2022, Journal of Nutritional Science and Vitaminology CrossRef
3. ITF2357 induces cell cycle arrest and apoptosis of meningioma cells via the PI3K-Akt pathway
   Lingying Zhang et al, 2022, Medical Oncology CrossRef
4. Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
   Somayye Taghvaei et al, 2021, Frontiers in Pharmacology CrossRef
5. Adverse effects of SYP-3343 on zebrafish development via ROS-mediated mitochondrial dysfunction
   Guoliang Chen et al, 2022, Journal of Hazardous Materials CrossRef
6. Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation
   Yan Wang et al, 2022, Asia-Pacific Journal of Clinical Oncology CrossRef
7. Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs
   Katarzyna Regulska et al, 2019, Pharmacological Research CrossRef
8. Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux
   Mohammad Rasheduzzaman et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
9. Telmisartan anti‐cancer activities mechanism through targeting N‐cadherin by mimicking ADH‐1 function
   Marjan Khorsand et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
10. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
    José A. Carlos-Escalante et al, 2021, Frontiers in Oncology CrossRef
11. Elucidating the Association Between the Upregulation of Angiotensin Type 1-Receptors and the Development of Gastrointestinal Malignancies
    Mohammad-Hassan Arjmand, 2021, Journal of Gastrointestinal Cancer CrossRef
12. Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells
    Thidarath Rattanaburee et al, 2022, Molecules CrossRef
13. Evolution of the Experimental Models of Cholangiocarcinoma
    Annamaria Massa et al, 2020, Cancers CrossRef
14. Telmisartan-Induced Cytotoxicity via G₂/M Phase Arrest in Renal Cell Carcinoma Cell Lines
    Yoshie Tsujiya et al, 2021, Biological and Pharmaceutical Bulletin CrossRef
15. Angiotensin II and Angiotensin Receptors 1 and 2—Multifunctional System in Cells Biology, What Do We Know?
    Maksymilian Ziaja et al, 2021, Cells CrossRef
16. Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinoma
    Jingcheng Hao et al, 2021, Oncology Reports CrossRef
17. Angiotensin Receptor Blocker Associated with a Decreased Risk of Lung Cancer: An Updated Meta-Analysis
    Zexu Wang et al, 2023, Journal of Personalized Medicine CrossRef
18. Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells
    Anna M. Schoepf et al, 2020, European Journal of Medicinal Chemistry CrossRef
19. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
    Richard E. Kast et al, 2022, Cancers CrossRef
20. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
    Diego F. Calvisi et al, 2023, Nature Reviews Gastroenterology & Hepatology CrossRef
21. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium
    Alessandra Gentilini et al, 2018, International Journal of Molecular Sciences CrossRef
22. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo
    Takanori Matsui et al, 2019, International Journal of Molecular Sciences CrossRef
23. In Vitro Drug Repurposing: Focus on Vasodilators
    Eduarda Ribeiro et al, 2023, Cells CrossRef
24. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis
    Junjie Kong et al, 2020, Cancer Biomarkers CrossRef
25. Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma
    Zai-Fa Hong et al, 2020, Biomedicine & Pharmacotherapy CrossRef
26. Animal models of cholangiocarcinoma
    Emilien Loeuillard et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
27. ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications
    Wook Jin, 2020, Journal of Clinical Medicine CrossRef
28. The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis
    Shin Ishikane et al, 2018, Biochemical Pharmacology CrossRef